×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Overview
Click Here to View the Program in Japanese
Membership is required to participate in DIA Community Day. Those whose membership qualifications have expired and non-members must apply after registering as members.
Program Committee
-
Goshi Ozawa, MS Representative Director & President, Japan / R&D Head
Juniper Therapeutix K.K., Japan -
Noriaki Nagao, MPharm, PMP Director, Clinical Development Dept. , Pharmaceutical Division
JAPAN TOBACCO INC., Japan -
Sonoko Misawa, MD, PhD Associate Professor, Department of Neurology
Chiba University Graduate of Medicine, Japan -
Taro Amagasaki, PhD Head, Analytics Japan
Novartis Pharma K.K., Japan -
Yuu Jincho, JD, MSc Manager, Data Practice Group, Biomedical Data Sciences Dept., RD Japan
GlaxoSmithKline K.K., Japan -
Miyuki Kaneko Japan Regulatory Portfolio Lead, Regulatory Affairs
Pfizer R&D Japan G.K., Japan -
Keiko Katsui, PhD Division of Research Integrity and Social Co-Creation
Japan Agency for Medical Research and Development (AMED), Japan -
Kana Maruyama Manager, Regulatory Labeling, Regulatory Affairs
Viatris Pharmaceuticals Japan Inc., Japan -
Yukihiro Matsuda, MSc Director, Clinical Delivery
ICON Clinical Research GK, Japan -
Kotone Matsuyama, RPh Professor, Department of Health Policy and Management
Nippon Medical School, Japan -
Hiroyuki Murakami Duputy Review Director, Office of New Drug I
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Tomohiko Takahashi Associate Manager, Headquarters of Clinical Development
Otsuka Pharmaceutical Co., Ltd., Japan -
Tadashi Urashima, PhD Performance and Digital Analytics Lead, Medical & Development Excellence Japan
GlaxoSmithKline K.K., Japan
Have an account?